Hrt Financial LP Castle Biosciences Inc Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$18.06 - $25.3 $271,098 - $379,778	15,011 New	15,011 $332,000
Q1 2023 May 12, 2023	BUY	$19.47 - $28.49 $292,205 - $427,577	15,008 New	15,008 $340,000
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $539,091 - $821,929	23,949 New	23,949 $624,000
Q4 2021 Feb 14, 2022	SELL	$39.06 - $67.58 $184,558 - $319,315	-4,725 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $284,114 - $366,660	4,725 New	4,725 $314,000
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $519,733 - $858,547	-8,821 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $384,595 - $644,374	8,821 New	8,821 $592,000

171

25.5M

511K

130K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $733M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.